Emtricitabine + Tenofovir Alafenamide

Uses

Emtricitabine and Tenofovir Alafenamide are used in the treatment of HIV infection.

How it Works

How Emtricitabine and Tenofovir Alafenamide Work Emtricitabine and tenofovir alafenamide are a combination of two medications that belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Emtricitabine disrupts the viral life cycle by inhibiting a key enzyme called HIV-1 reverse transcriptase. Tenofovir alafenamide is converted to tenofovir diphosphate, which is incorporated into viral DNA, leading to the inhibition of HIV replication.

Side Effects

Common side effects of Emtricitabine and Tenofovir Alafenamide include nausea, diarrhea, headache, depression, rash, dizziness, fatigue, vomiting, insomnia (difficulty sleeping), weakness, allergic reactions, abnormal dreams, decreased phosphate levels in the blood, decreased white blood cell count (neutrophils), increased triglyceride levels in the blood, abdominal pain, weight loss, upper respiratory tract infections, increased transaminase levels in the blood, increased glucose levels in the blood, elevated serum amylase levels, increased lipase levels in the blood, and elevated creatine kinase levels.

Expert Advice

  • Emtricitabine + Tenofovir Alafenamide may weaken your bones.
  • Exercise regularly and take calcium and vitamin D supplements as recommended by your doctor.
  • Although treatment with Emtricitabine + Tenofovir Alafenamide can reduce the risk of transmitting HIV to others through sexual contact, it does not eliminate the risk.
  • It is important to use condoms during sexual activity.
  • Inform your doctor immediately if you develop any infections soon after starting Emtricitabine + Tenofovir Alafenamide.
  • Your doctor may prescribe blood tests to check for hepatitis B virus infection before starting treatment with Emtricitabine + Tenofovir Alafenamide.
  • Increase your fluid intake and maintain a healthy diet during your treatment with Emtricitabine + Tenofovir Alafenamide.
  • Avoid sharing personal belongings, such as razors or toothbrushes, with family members.
  • It is common for individuals with HIV to experience feelings of low mood or depression, especially soon after diagnosis.
  • If you experience any feelings of depression, it is advisable to discuss them with your doctor.

Related Medications

Molecule
Salt Composition in both

Bictegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg

hero_image
Taftrio 50mg/200mg/25mg Tablet
Hetero Healthcare Ltd.
Bottle of 30 tablets
MRP

4,800

hero_image
Taffic Tablet 30s
Hetero Healthcare Ltd.
Bottle of 30 tablets

3,690

MRP 4,500

23% Savings
Molecule
Salt Composition

Bictegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg

hero_image
Taffic Tablet 30s
Hetero Healthcare Ltd.
Bottle of 30 tablets

3,690

18% OFF

MRP 4,500

Molecule
Salt Composition in both

Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg

hero_image
Spegra Tablet 90s
Emcure Pharmaceuticals Ltd.
Bottle of 90 tablets
MRP

13,165.5

hero_image
Spegra Tablet 30s
Emcure Pharmaceuticals Ltd.
Bottle of 30 tablets

3,707.7

MRP 4,521.5

16% Savings
Molecule
Salt Composition

Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg

hero_image
Spegra Tablet 30s
Emcure Pharmaceuticals Ltd.
Bottle of 30 tablets

3,707.7

18% OFF

MRP 4,521.5

Molecule
Salt Composition in both

Bictegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg

hero_image
3 Mune Tablet 30s
Cipla Ltd.
Strip of 30 tablets
MRP

425

hero_image
Taffic Tablet 30s
Hetero Healthcare Ltd.
Bottle of 30 tablets

3,690

MRP 4,500

Top Brand
Molecule
Salt Composition in both

Emtricitabine 200mg + Tenofovir Alafenamide 25mg

hero_image
Tafmune EM 200mg/25mg Tablet
Cipla Ltd.
Strip of 30 tablets
MRP

1,859.1

hero_image
Tafero EM 200/25mg Tablet 30s
Hetero Healthcare Ltd.
Bottle of 30 tablets

1,439

MRP 1,821.6

23% Savings
Molecule
Salt Composition

Emtricitabine 200mg + Tenofovir Alafenamide 25mg

hero_image
Tafero EM 200/25mg Tablet 30s
Hetero Healthcare Ltd.
Bottle of 30 tablets

1,439

21% OFF

MRP 1,821.6

Frequently asked questions

Adults and pediatric patients aged 12 and older should take one tablet of Emtricitabine+Tenofovir Alafenamide orally once daily, with or without food. Always adhere to your doctor's instructions and avoid self-medication.
Emtricitabine+Tenofovir Alafenamide is a combination of antiretroviral medications used to treat HIV, the virus that can lead to AIDS. It helps control HIV infection, allowing the immune system to function more effectively.
Yes, Emtricitabine+Tenofovir Alafenamide may weaken bones, increasing the risk of brittleness. A bone mineral density test may be prescribed if you have a history of fractures or conditions like osteoporosis.
No, Emtricitabine+Tenofovir Alafenamide is not recommended for individuals with severe kidney disease (creatinine clearance below 30 mL/min). Consult your doctor for more information.
No, Emtricitabine+Tenofovir Alafenamide is not approved for treating chronic HBV infection, and its safety and efficacy in patients co-infected with HIV-1 and HBV have not been established. Patients with HIV-1 should be tested for chronic HBV before starting this therapy.
Yes, flu-like symptoms may occur as your immune system strengthens and starts to combat previously hidden infections. Consult your doctor if you notice any health changes.
No, Emtricitabine+Tenofovir Alafenamide does not prevent HIV transmission during sex. It is crucial to practice safe sex using barrier methods, such as latex condoms, even if your partner is also HIV-positive. Seek your doctor's advice.
;